A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Bone and Soft Tissue Tumors

Conditions: Osteosarcoma; Sarcoma; Soft Tissue Sarcoma; Bone Tumor Interventions: Drug: Recombinant oncolytic herpes simplex virus type Ⅰ (R130) Sponsors: Shanghai Yunying Medical Technology; Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials